
|Videos|January 20, 2022
How appropriate use criteria was created for PSMA-PET imaging
Author(s)Urology Times staff
“There is a rather extensive process of how to develop appropriate use criteria. It is primarily based on literature and evidence, systematic reviews, and analysis of those data,” says Hossein Jadvar, MD, PhD.
Advertisement
In this video, Hossein Jadvar, MD, PhD, discusses the process for creating the appropriate use criteria for prostate-specific membrane antigen (PSMA) PET imaging that was recently released in the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
Mary Dunn, MSN, NP-C, OCN, RN, on advances reshaping advanced prostate cancer care
5










